Entheon Biomedical Corp. (ENTBF)
OTCMKTS
· Delayed Price · Currency is USD
0.0720
-0.0080 (-10.00%)
Jul 14, 2025, 4:00 PM EDT
Entheon Biomedical Statistics
Total Valuation
ENTBF has a market cap or net worth of 1.01 million. The enterprise value is 628,814.
Market Cap | 1.01M |
Enterprise Value | 628,814 |
Important Dates
The last earnings date was Monday, June 30, 2025.
Earnings Date | Jun 30, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 13.86M |
Shares Outstanding | n/a |
Shares Change (YoY) | +56.84% |
Shares Change (QoQ) | +35.87% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 13.58M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 2.92 |
P/TBV Ratio | 2.92 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -2.33 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.80
Current Ratio | 8.80 |
Quick Ratio | 8.37 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -104.96% and return on invested capital (ROIC) is -68.18%.
Return on Equity (ROE) | -104.96% |
Return on Assets (ROA) | -59.05% |
Return on Invested Capital (ROIC) | -68.18% |
Return on Capital Employed (ROCE) | -80.83% |
Revenue Per Employee | n/a |
Profits Per Employee | -269,326 |
Employee Count | 1 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.72% in the last 52 weeks. The beta is 1.60, so ENTBF's price volatility has been higher than the market average.
Beta (5Y) | 1.60 |
52-Week Price Change | -22.72% |
50-Day Moving Average | 0.08 |
200-Day Moving Average | 0.11 |
Relative Strength Index (RSI) | 47.85 |
Average Volume (20 Days) | 388 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -279,901 |
Pretax Income | -269,326 |
Net Income | -269,326 |
EBITDA | n/a |
EBIT | -279,901 |
Earnings Per Share (EPS) | -0.03 |
Balance Sheet
The company has 363,905 in cash and n/a in debt, giving a net cash position of 363,905.
Cash & Cash Equivalents | 363,905 |
Total Debt | n/a |
Net Cash | 363,905 |
Net Cash Per Share | n/a |
Equity (Book Value) | 346,275 |
Book Value Per Share | 0.02 |
Working Capital | 342,810 |
Cash Flow
Operating Cash Flow | -257,953 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ENTBF does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -56.84% |
Shareholder Yield | n/a |
Earnings Yield | -26.60% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on March 1, 2024. It was a reverse split with a ratio of 0.1.
Last Split Date | Mar 1, 2024 |
Split Type | Reverse |
Split Ratio | 0.1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |